← Back to Clinical Trials
Recruiting NCT05134779
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
Trial Parameters
Condition Breast Cancer
Sponsor Weill Medical College of Cornell University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 400
Sex FEMALE
Min Age 18 Years
Max Age 90 Years
Start Date 2022-01-12
Completion 2027-12-31
Interventions
Live Biobank
Brief Summary
This is a live biobank study for breast cancer (BC) patients where samples will be collected at inflection points in the course of the disease.
Eligibility Criteria
Inclusion Criteria: * All patients will historically proven BC are eligible to be on the study Exclusion Criteria: * Carriers of other cancers other than breast.
Related Trials
NCT06686394
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breas
View Trial →
NCT04656639
Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer
View Trial →
NCT05288777
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
View Trial →